Psychiatry

Canadian Paediatric Society outlines efficacy, risks, and monitoring guidelines.

Standards of care are needed for the use of psychotropics in children with ASD.

Shire Canada is introducing Intuniv XR (guanfacine 1 mg, 2 mg, 3mg, and 4 mg extended-release tablets), the first selective alpha2A-adrenergic receptor agonist to be approved for the treatment of attention deficit hyperactivity disorder (ADHD) in Canada.

Check out our review of recent psychiatric stories in the media - Top Story: New campaign aims to increase mental health resources, reduce youth suicide rates in Canada. Read this and

New website expands on print publication to include more than 80 new medications

But author laments ‘huge gap’ between recommendations and real-world care

Manitoba studies pinpoint the warning signs doctors should look for

Psychotherapy and exercise address anxiety and depression